VB-0220

Anlage 3 Liste der Suchtmittel, geordnet nach Positionen der Kombinierten Nomenklatur Hinweis: In der Spalte "Anlage" bedeuten: Aes handelt sich um ein in den Anhängen I bis V der Suchtgiftverordnung (siehe Anlage 1) genanntes Suchtgift; der jeweilige Anhang der Suchtgiftverordnung wird durch den Zusatz "(Anhang I)", "(Anhang II)", "(Anhang III)", "(Anhang IV)" oder "(Anhang V)" angegeben; Bes handelt sich um einen in der Anlage 1 der Psychotropenverordnung (siehe Anlage 2) genannten Stoff. Warenkatalog: | KN-Code | Warenbezeichnung | Abschnitt | ex | 0602 90 50 | Hanfpflanzen | A (Anhang I) und Abschnitt 1.1.4. | ex | 0604 20 90 | Mohnstroh (Mohnkapseln) | Abschnitt 1.1.3. |   |   | Hanfpflanzen | A (Anhang I) und Abschnitt 1.1.4. |   | 0604 90 91 0604 90 99 | Mohnstroh (Mohnkapseln) | Abschnitt 1.1.3. |   |   | Hanfpflanzen | A (Anhang I) und Abschnitt 1.1.4. |   | 1211 30 | Cocablätter | A (Anhang I) | ex | 1211 90 86 | Cannabis | A (Anhang I) | ex | 1301 90 | Cannabisharz (Haschisch) | A (Anhang I) |   | 1302 11 | Opium, Rohopium | A (Anhang I) | ex | 1302 19 70 | Cannabis-Extrakte und -Tinkturen | A (Anhang I) |   |   | Mohnstrohkonzentrat | A (Anhang I) | ex | 1404 90 | Mohnstroh (Mohnkapseln) | Abschnitt 1.1.3. | ex | 2905 51 | Ethchlorvynol | B (Anlage 2) | ex | 2918 19 98 | GHB (Gamma-Hydroxybutyrat-Acid) | A (Anhang IV) |   | 2921 46 | Amfetamin | A (Anhang IV) |   |   | Benzfetamin | B (Anlage 2) |   |   | Dexamphetamin | A (Anhang IV) |   |   | Etilamfetamin | B (Anlage 2) |   |   | Fencamfamin | B (Anlage 2) |   |   | Lefetamin | B (Anlage 2) |   |   | Levamfetamin | A (Anhang IV) |   |   | Mefenorex | B (Anlage 2) |   |   | Phentermin | B (Anlage 2) | ex | 2921 49 | 4-Fluoroamphetamin, 4-FA | A (Anhang IV) |   |   | 4-Methylamphetamin | A (Anhang V) |   |   | Eticyclidin | A (Anhang V) |   |   | PCE | A (Anhang V) |   | 2922 14 | Dextropropoxyphen | A (Anhang II) | ex | 2922 19 | Acetylmethadol | A (Anhang I) |   |   | Alphacetylmethadol | A (Anhang I) |   |   | Alphamethadol | A (Anhang I) |   |   | Betacetylmethadol | A (Anhang I) |   |   | Betamethadol | A (Anhang I) |   |   | Dimenoxadol | A (Anhang I) |   |   | Dimepheptanol | A (Anhang I) |   |   | Levacetylmethadol | A (Anhang I) |   |   | Noracymethadol | A (Anhang I) | ex | 2922 29 | 25B-NBOMe, 2C-B-NBOMe | A (Anhang V) |   |   | 25C-NBOMe, 2C-C-NBOMe | A (Anhang V) |   |   | 25I-NBOMe, 2C-I-NBOMe | A (Anhang V) |   |   | Brolamfetamin | A (Anhang V) |   |   | DOB | A (Anhang V) |   |   | DOET | A (Anhang V) |   |   | DOM | A (Anhang V) |   |   | STP | A (Anhang V) |   |   | DMA | A (Anhang V) |   |   | PMA | A (Anhang V) |   |   | Tepentadol | A (Anhang I) |   |   | TMA | A (Anhang V) |   |   | TMA-2 (2,3,4-Trimethoxyamphetamin) | A (Anhang V) |   |   | 2C-I (4-Iod-2,5-dimethoxyphenylethylamin) | A (Anhang V) |   | 2922 31 | Amfepramon | B (Anlage 2) |   |   | Methadon, einschließlich Isomethadon und Levo-(R(-)) Methadon (Polamidon) | A (Anhang I) |   |   | Normethadon | A (Anhang I) |   | 2922 44 | Tilidin | A (Anhang I) | ex | 2922 50 | Methoxetamin, MXE | A (Anhang IV) |   |   | Tramadol | A (Anhang IV) |   | 2924 11 | Meprobamat | B (Anlage 2) | ex | 2924 24 | Ethinamat | B (Anlage 2) | ex | 2924 29 70 | AH-7921 | A (Anhang I) |   |   | Diampromid | A (Anhang I) |   |   | U-47700 | A (Anhang I) |   | 2925 12 | Glutethimid | B (Anlage 2) |   | 2926 30 | Methadon-Zwischenprodukt | A (Anhang I) |   |   | Fenproporex | B (Anlage 2) | ex | 2930 90 98 | 4-MTA | A (Anhang V) |   | 2932 95 | Tetrahydrocannabinole (=THCA) und die im Anhang V angeführten Isomere | A (Anhang V) | ex | 2932 99 | Delta-9-Tetrahydrocannabinol synthetischen Ursprungs und deren stereochemischen Varianten | A (Anhang IV) |   |   | Ethylon | A (Anhang IV) |   |   | Methylon, beta-keto-MDMA | A (Anhang IV) |   |   | MBDB | A (Anhang V) |   |   | MDA | A (Anhang V) |   |   | MDE | A (Anhang V) |   |   | MDMA | A (Anhang V) |   |   | N-Äthyl MDA | A (Anhang V) |   |   | N-Ethylnorpentylon, Ephylon | A (Anhang IV) |   |   | Tenamfetamin | A (Anhang V) |   |   | DMHP | A (Anhang V) |   |   | MMDA | A (Anhang V) |   |   | N-Hydroxy MDA | A (Anhang V) |   |   | Parahexyl | A (Anhang V) | ex | 2933 33 | Alfentanil | A (Anhang I) |   |   | Anileridin | A (Anhang I) |   |   | Bezitramid | A (Anhang I) |   |   | Bromazepam | B (Anlage 2) |   |   | Difenoxin | A (Anhang I) |   |   | Diphenoxylat | A (Anhang I) |   |   | Dipipanon | A (Anhang I) |   |   | Fentanyl | A (Anhang I) |   |   | Ketobemidon | A (Anhang I) |   |   | Methylphenidat | A (Anhang IV) |   |   | Pentazocin | A (Anhang IV) |   |   | Pethidin | A (Anhang I) |   |   | Pethidin-Zwischenprodukt A | A (Anhang I) |   |   | Phencyclidin | A (Anhang IV) |   |   | Phenoperidin | A (Anhang I) |   |   | Pipradol | B (Anlage 2) |   |   | Piritramid | A (Anhang I) |   |   | Propiram | A (Anhang II) |   |   | Trimeperidin | A (Anhang I) | ex | 2933 39 99 | 4-Fluoroisobutyrfentanyl, 4-FIBF, pFIBF | A (Anhang I) |   |   | Acetyl-alpha-methylfentanyl | A (Anhang I) |   |   | Acetylfentanyl | A (Anhang I) |   |   | Acryloylfentanyl | A (Anhang I) |   |   | Allylprodin | A (Anhang I) |   |   | Alpha-methylfentanyl | A (Anhang I) |   |   | Alphameprodin | A (Anhang I) |   |   | Alphaprodin | A (Anhang I) |   |   | Benzethidin | A (Anhang I) |   |   | Beta-hydroxy-3-methylfentanyl | A (Anhang I) |   |   | Beta-hydroxyfentanyl | A (Anhang I) |   |   | Betameprodin | A (Anhang I) |   |   | Betaprodin | A (Anhang I) |   |   | Butyrfentanyl | A (Anhang I) |   |   | Carfentanil | A (Anhang I) |   |   | Cyclopropylfentanyl | A (Anhang I) |   |   | Ethylphenidat | A (Anhang IV) |   |   | Etoxeridin | A (Anhang I) |   |   | Hydroxypethidin | A (Anhang I) |   |   | Metazocin | A (Anhang I) |   |   | Methoxyacetylfentanyl | A (Anhang I) |   |   | 3-Methylfentanyl | A (Anhang I) |   |   | MPPP | A (Anhang I) |   |   | Norpipanon | A (Anhang I) |   |   | Ocfentanil | A (Anhang I) |   |   | Orthoflourofentanyl | A (Anhang I) |   |   | Parafluorobutyrylfentanyl | A (Anhang I) |   |   | Para-fluorofentanyl | A (Anhang I) |   |   | PEPAP | A (Anhang I) |   |   | Pethidin-Zwischenprodukt B | A (Anhang I) |   |   | Pethidin-Zwischenprodukt C | A (Anhang I) |   |   | Phenampromid | A (Anhang I) |   |   | Phenazocin | A (Anhang I) |   |   | Piminodin | A (Anhang I) |   |   | Properidin | A (Anhang I) |   |   | Remifentanil | A (Anhang I) |   | 2933 41 | Levorphanol | A (Anhang I) | ex | 2933 49 90 | 5F-PB-22 | A (Anhang IV) |   |   | Drotebanol | A (Anhang I) |   |   | Levomethorphan, ausgenommen Dextromethorphan | A (Anhang I) |   |   | Levophenacylmorphan | A (Anhang I) |   |   | Norlevorphanol | A (Anhang I) |   |   | Phenomorphan | A (Anhang I) |   |   | Phenomorphan | A (Anhang I) |   |   | Racemethorphan | A (Anhang I) |   |   | Racemorphan | A (Anhang I) |   | 2933 53 | Amobarbital | B (Anlage 2) |   |   | Barbital | B (Anlage 2) |   |   | Phenobarbital | B (Anlage 2) |   |   | Allobarbital | B (Anlage 2) |   |   | Butalbital | B (Anlage 2) |   |   | Butobarbital | B (Anlage 2) |   |   | Cyclobarbital | B (Anlage 2) |   |   | Methylphenobarbital | B (Anlage 2) |   |   | Pentobarbital | B (Anlage 2) |   |   | Secbutabarbital | B (Anlage 2) |   |   | Secobarbital | A (Anhang IV) |   |   | Vinylbital | B (Anlage 2) |   | 2933 55 | Loprazolam | B (Anlage 2) |   |   | Mecloqualon | A (Anhang IV) |   |   | Methaqualon | A (Anhang IV) |   |   | Zipeprol | A (Anhang IV) | ex | 2933 59 95 | Benzylpiperazin (BZP) | A (Anhang V) |   |   | MT-45 | A (Anhang I) |   | 2933 72 | Clobazam | B (Anlage 2) |   |   | Methyprylon | B (Anlage 2) | ex | 2933 91 90 | Alprazolam | B (Anlage 2) |   |   | α-Pyrrolidinovalerophenon, α-PVP | A (Anhang IV) |   |   | Camazepam | B (Anlage 2) |   |   | Clonazepam | B (Anlage 2) |   |   | Diazepam | B (Anlage 2) |   |   | Estazolam | B (Anlage 2) |   |   | Ethylloflazepate | B (Anlage 2) |   |   | Fludiazepam | B (Anlage 2) |   |   | Flunitrazepam | B (Anlage 2) |   |   | Flurazepam | B (Anlage 2) |   |   | Halazepam | B (Anlage 2) |   |   | Lorazepam | B (Anlage 2) |   |   | Lormetazepam | B (Anlage 2) |   |   | Medazepam | B (Anlage 2) |   |   | Midazolam | B (Anlage 2) |   |   | Nimetazepam | B (Anlage 2) |   |   | Nitrazepam | B (Anlage 2) |   |   | Nordazepam | B (Anlage 2) |   |   | Oxazepam | B (Anlage 2) |   |   | Pinazepam | B (Anlage 2) |   |   | Prazepam | B (Anlage 2) |   |   | Temazepam | B (Anlage 2) |   |   | Tetrazepam | B (Anlage 2) |   |   | Triazolam | B (Anlage 2) |   |   | Chlordiazepoxid | B (Anlage 2) |   |   | Clorazepat | B (Anlage 2) |   |   | Delorazepam | B (Anlage 2) |   |   | Mazindol | B (Anlage 2) |   |   | Pyrovaleron | B (Anlage 2) | ex | 2933 99 80 | 5-(2-Aminopropyl)indol | A (Anhang V) |   |   | 5F-APINACA, 5F-AKB-48 | A (Anhang IV) |   |   | 5F-MDMB-PINACA, 5F-ADB | A (Anhang IV) |   |   | AB-CHMINACA | A (Anhang IV) |   |   | AB-PINACA | A (Anhang IV) |   |   | ADB-CHMINACA | A (Anhang V) |   |   | AMB-FUBINACA | A (Anhang IV) |   |   | AM-2201 | A (Anhang IV) |   |   | Clonitazen | A (Anhang I) |   |   | CUMYL-4CN-BINACA | A (Anhang V) |   |   | Etonitazen | A (Anhang I) |   |   | Etryptamin | A (Anhang V) |   |   | FUB-AMB, MMB-FUBINACA, AMB-FUBINACA | A (Anhang IV) |   |   | JWH-018 | A (Anhang IV) |   |   | MDMB-CHMICA | A (Anhang IV) |   |   | PCPY | A (Anhang V) |   |   | Phenazepam | B (Anlage 2) |   |   | PHP | A (Anhang V) |   |   | Proheptazin | A (Anhang I) |   |   | Rolicyclidin | A (Anhang V) |   |   | UR-144 | A (Anhang IV) |   |   | XLR-11 | A (Anhang IV) |   |   | Zolpidem | B (Anlage 2) |   | 2934 91 | Aminorex | B (Anlage 2) |   |   | Brotizolam | B (Anlage 2) |   |   | Clotiazepam | B (Anlage 2) |   |   | Cloxazolam | B (Anlage 2) |   |   | Dextromoramid | A (Anhang I) |   |   | Haloxazolam | B (Anlage 2) |   |   | Ketazolam | B (Anlage 2) |   |   | Mesocarb | B (Anlage 2) |   |   | Oxazolam | B (Anlage 2) |   |   | Pemolin | B (Anlage 2) |   |   | Phendimetrazin | B (Anlage 2) |   |   | Phenmetrazin | A (Anhang IV) |   |   | Sufentanil | A (Anhang I) |   | 2934 99 90 | Alpha-methylthiofentanyl | A (Anhang I) |   |   | 3,4-Methylendioxypyrovaleron, MDPV | A (Anhang IV) |   |   | 3-Methylthiofentanyl | A (Anhang I) |   |   | Diethylthiambuten | A (Anhang I) |   |   | Dimethylthiambuten | A (Anhang I) |   |   | Dioxaphetylbutyrat | A (Anhang I) |   |   | Ethylmethylthiambuten | A (Anhang I) |   |   | Furanylfentanyl | A (Anhang I) |   |   | Furethidin | A (Anhang I) |   |   | Levomoramid | A (Anhang I) |   |   | Methiopropamin, MPA | A (Anhang IV) |   |   | 4-Methylaminorex | A (Anhang V) |   |   | Moramid-Zwischenprodukt | A (Anhang I) |   |   | Morpheridin | A (Anhang I) |   |   | Paramethyl-4-methylaminorex, 4,4'-DMAR | A (Anhang IV) |   |   | Phenadoxon | A (Anhang I) |   |   | Racemoramid | A (Anhang I) |   |   | Tenocyclidin (=TCP) | A (Anhang V) |   |   | Tetrahydrofuranylfentanyl, THF-F | A (Anhang I) |   |   | 2-C-T-2 (2,5-Dimethoxy-4-ethylthiophenylethylamin) | A (Anhang V) |   |   | 2-C-T-7 (2,5-Dimethoxy-4(n)-propylthiophenylethylamin) | A (Anhang V) |   |   | Phendimetrazin | B (Anlage 2) |   |   | Phenmetrazin | A (Anhang IV) |   |   | Sufentanil | A (Anhang I) |   | 2939 11 | Buprenorphin | A (Anhang IV) |   |   | Codein | A (Anhang II) |   |   | Diacetylmorphin (Heroin) | A (Anhang I) |   |   | Dihydrocodein | A (Anhang II) |   |   | Ethylmorphin (Äthylmorphin) | A (Anhang II) |   |   | Etorphin | A (Anhang I) |   |   | Heroin, Diacetylmorphin | A (Anhang I) |   |   | Hydrocodon | A (Anhang I) |   |   | Hydromorphon | A (Anhang I) |   |   | Mohnstrohkonzentrat | A (Anhang I) |   |   | Morphin | A (Anhang I) |   |   | Nicomorphin | A (Anhang I) |   |   | Oxycodon | A (Anhang I) |   |   | Oxymorphon | A (Anhang I) |   |   | Pholcodin | A (Anhang II) |   |   | Thebacon | A (Anhang I) |   |   | Thebain | A (Anhang I) | ex | 2939 19 | Acetorphin | A (Anhang I) |   |   | Acetyldihydrocodein | A (Anhang II |   |   | Benzylmorphin | A (Anhang I) |   |   | Codein-N-oxid | A (Anhang I) |   |   | Codoxim | A (Anhang I) |   |   | Desomorphin | A (Anhang I) |   |   | Dihydromorphin | A (Anhang I) |   |   | Hydromorphinol | A (Anhang I) |   |   | Methyldesorphin | A (Anhang I) |   |   | Methyldihydromorphin | A (Anhang I) |   |   | Metopon | A (Anhang I) |   |   | Monoacetylmorphin, 6-Acetyl-Morphin | A (Anhang I) |   |   | Morphinmethobromid und andere quartäre Salze des Morphins | A (Anhang I) |   |   | Morphin-N-oxid | A (Anhang I) |   |   | Myrophin | A (Anhang I) |   |   | Nicocodin | A (Anhang II |   |   | Nicodicodin | A (Anhang II |   |   | Norcodein | A (Anhang II |   |   | Normorphin | A (Anhang I) |   |   | Oripavin | A (Anhang I) |   | 2939 43 | Cathin | B (Anlage 2) | ex | 2939 44 | (+)-Norpseudoephedrin | B (Anlage 2) |   | 2939 51 | Fenetyllin | A (Anhang IV) | ex | 2939 69 | LSD, LSD-25, (+)-Lysergid | A (Anhang V) | ex | 2939 71 | Levomethamphetamin | A (Anhang IV) |   |   | Cocain | A (Anhang I) |   |   | Ecgonin | A (Anhang I) |   |   | Metamphetamin-Razemat | A (Anhang IV) |   |   | Methamphetamin | A (Anhang IV) |   |   | PMMA (Anhang Anhang Paramethoxymethamphetamin) | A (Anhang V) | ex ex | 2939 79 2939 80 | 2C-B (4-Bromo-2,5 dimethoxyphenethylamin) | A (Anhang V) |   |   | Cathinon | A (Anhang V) |   |   | DET | A (Anhang V) |   |   | DMT | A (Anhang V) |   |   | Mescalin | A (Anhang V) |   |   | Methcathinon | A (Anhang V) |   |   | 4-Methylethcathinon, 4-MEC | A (Anhang IV) |   |   | 4-Methyl-Methcathinon ("Mephedron") | A (Anhang V) |   |   | Pentedron | A (Anhang IV) |   |   | Psilocin, Psilotin | A (Anhang V) |   |   | Psilocybin | A (Anhang V) |   |   | Thiofentanyl | A (Anhang I) | ex | 3001 | Waren dieser Position, sofern sie Suchtmittel enthalten | A (Anlage 1, Anhang I - V), B (Anlage 2) | ex | 3002 | Waren dieser Position, sofern sie Suchtmittel enthalten | A (Anlage 1, Anhang I - V), B (Anlage 2) | ex | 3003 | Waren dieser Position, sofern sie Suchtmittel enthalten | A (Anlage 1, Anhang I - V), B (Anlage 2) | ex | 3004 | Waren dieser Position, sofern sie Suchtmittel enthalten | A (Anlage 1, Anhang I - V), B (Anlage 2)